Clinical Trial Update: Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cytokine-induced killer cell therapy after resection of hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Cytokine-induced killer cells

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED